|
SGK269 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.756800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.380200E-03 |
| Normal-vs-Stage2 |
4.287600E-01 |
| Normal-vs-Stage3 |
6.744100E-03 |
| Normal-vs-Stage4 |
1.188780E-01 |
| Stage1-vs-Stage2 |
2.905600E-01 |
| Stage1-vs-Stage3 |
7.221000E-01 |
| Stage1-vs-Stage4 |
6.822000E-01 |
| Stage2-vs-Stage3 |
1.947970E-01 |
| Stage2-vs-Stage4 |
3.043800E-01 |
| Stage3-vs-Stage4 |
8.470800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.420600E-03 |
| Normal-vs-AfricanAmerican |
1.010170E-01 |
| Normal-vs-Asian |
3.218500E-02 |
| Caucasian-vs-AfricanAmerican |
4.695000E-01 |
| Caucasian-vs-Asian |
6.433000E-01 |
| AfricanAmerican-vs-Asian |
4.937800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.219700E-04 |
| Normal-vs-Female |
5.565200E-01 |
| Male-vs-Female |
8.579100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.475780E-02 |
| Normal-vs-Extreme_Weight |
5.978200E-04 |
| Normal-vs-Obese |
9.117800E-02 |
| Normal-vs-Extreme_Obese |
6.135800E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.402200E-01 |
| Normal_Weight-vs-Obese |
3.352400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.002400E-01 |
| Extreme_Weight-vs-Obese |
9.747800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.608800E-01 |
| Obese-vs-Extreme_Obese |
1.936570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.279000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.302600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.988600E-04 |
| Normal-vs-Age(81-100Yrs) |
9.772600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.549400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.883830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.810400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.008300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.505800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.837800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.856410E-02 |
| Normal-VS-Type2 PRCC |
1.6752999999925E-05 |
| Normal-VS-KIRP CIMP |
7.342200E-01 |
| Normal-VS-Unclassified PRCC |
8.916800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.698900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.338000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.535000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.742000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.239760E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.154200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.227600E-04 |
| Normal-vs-N1 |
7.349700E-02 |
| Normal-vs-N2 |
2.550600E-01 |
| N0-vs-N1 |
3.032200E-01 |
| N0-vs-N2 |
5.702200E-01 |
| N1-vs-N2 |
9.770200E-01 |
|
|
